Physician profile
Sujay Dutta
NPI 1184712168
$7,883.25
in general payments reported to CMS, 2019-2025
32 companies · $3,330 in 2025
The $3,330 reported for 2025 was more than what 89% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,554 · 2020: $76.59 · 2021: $1,056 · 2022: $984 · 2023: $254 · 2024: $629 · 2025: $3,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,994 · Food and Beverage: $1,542 · Education: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,993.91 |
| Food and Beverage | $1,541.59 |
| Education | $678.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ets Wound Care LLC | $2,822.26 | 2025 | Mirragen Advanced Wound Matrix |
| Smith+Nephew, INC. | $684.32 | 2019-2023 | Grafix |
| Organogenesis INC. | $507.76 | 2019-2024 | Nushield |
| Next Science LLC | $448.19 | 2021-2022 | |
| Acera Surgical, INC. | $285.22 | 2022-2024 | Restrata Wound Matrix |
| Melinta Therapeutics, LLC | $244.35 | 2019-2024 | Rezzayo, Kimyrsa, Vabomere |
| Paratek Pharmaceuticals, INC. | $242.68 | 2022-2025 | Nuzyra |
| Biotissue Holdings INC. | $230.09 | 2021-2023 | |
| Shionogi INC | $208.67 | 2021-2024 | Fetroja |
| Abbvie INC. | $207.23 | 2021-2025 | |
| Gilead Sciences, INC. | $192.91 | 2019-2025 | Biktarvy |
| Kci USA, INC. | $186.09 | 2019-2022 | |
| Access Pro Medical, LLC | $153.57 | 2025 | Matriderm |
| Intuitive Surgical, INC. | $148.95 | 2019 | |
| Allergan, INC. | $143.03 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $134.70 | 2019 | |
| Urgo Medical North America, LLC | $108.06 | 2022-2024 | Urgoclean Ag |
| Kerecis Limited | $105.51 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $100.00 | 2024 | Truelok Evo |
| Insmed, INC. | $99.78 | 2019-2025 | Brinsupri, Arikayce |
| Integra Lifesciences Corporation | $95.52 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Viiv Healthcare Company | $86.18 | 2019-2021 | |
| Tetraphase Pharmaceuticals, INC. | $81.85 | 2019 | |
| Merck Sharp & Dohme LLC | $79.37 | 2019 | |
| Misonix INC | $75.30 | 2019 | |
| Cipla USA INC. | $70.28 | 2019-2020 | |
| Janssen Biotech, INC. | $28.69 | 2019 | |
| La Jolla Pharmaceutical Company | $28.54 | 2025 | Zevtera |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 | |
| Grifols USA, LLC | $25.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.08 | 2025 | Rebyota |
| Tactile Systems Technology INC | $14.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sujay Dutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.